AkzoNobel appoints new investor relations director
pharmafile | August 25, 2011 | Appointment | Sales and Marketing | appointment, sales and marketing
Jonathan Atack is set to join AkzoNobel as the company’s new corporate director of investor relations.
He was most recently chief financial offer at ING Investment Management in the Netherlands and will take up his new position on 1 October.
Prior to his time at ING, Jonathan worked in investor relations at easyJet, Royal Bank of Scotland and Six Continents.
“We are delighted to welcome Jonathan to AkzoNobel. His extensive experience at a variety of multinationals will bring valuable expertise to our team and further improve the professionalism of our investor relations,” said Keith Nichols, AkzoNobel’s chief financial officer.
Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …






